Phase II clinical trial - Sein métastatique RH+

PALATINE - UC-0140/1814

Sein métastatique RH+

Essai clinique fermé

Public cible

Adulte

ADVANCED BREAST CANCER: THERAPY INTEGRATING LOCOREGIONAL TREATMENT IN DE NOVO,;TREATMENT NAIVE, STAGE IV ER+, HER2- BREAST CANCER PATIENTS RECEIVING LETROZOLE AND;PALBOCICLIB

Description de l'essai

This study is a multicenter, single arm, Àsingle stage phase 2À clinical trial conducted in patients with;de novo stage IV ER-positive, HER2-negative breast cancer and naive of treatment. The aim is to;evaluate the efficacy of the combination of the standard systemic treatment with a loco-regional;treatment adapted to the patient situation (surgery and/or radiotherapy.